Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy
Background: Immune-related adverse events are associated with efficacy of immune checkpoint inhibitors (ICIs). We hypothesize that immune-mediated thrombocytopenia could be a biomarker for response to ICIs. Materials & methods: This retrospective study included 215 patients with metastatic malignanc...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Taylor & Francis Group
2020-08-01
|
| Серія: | Future Science OA |
| Предмети: | |
| Онлайн доступ: | https://www.future-science.com/doi/10.2144/fsoa-2020-0021 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|